152 related articles for article (PubMed ID: 32535811)
1. Intralesional Methotrexate for the Treatment of Advanced Keratinocytic Tumors: A Multi-Center Retrospective Study.
Gualdi G; Caravello S; Frasci F; Giuliani F; Moro R; Fargnoli MC; Ciciarelli V; Argenziano G; Giorgio CM; Requena C; Nagore E; Sanmartín O; Martorell A; Fantini F; Calzavara-Pinton P; Amerio P
Dermatol Ther (Heidelb); 2020 Aug; 10(4):769-777. PubMed ID: 32535811
[TBL] [Abstract][Full Text] [Related]
2. Treatment of keratoacanthoma: Is intralesional methotrexate an option?
Patel NP; Cervino AL
Can J Plast Surg; 2011; 19(2):e15-8. PubMed ID: 22654538
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Intralesional Methotrexate in the Treatment of a Large Keratoacanthoma of the Dorsal Hand in a 99-Year-Old Woman.
Della Valle V; Milani M
Case Rep Dermatol; 2018; 10(3):247-250. PubMed ID: 30519171
[TBL] [Abstract][Full Text] [Related]
4. Intralesional methotrexate for the treatment of keratoacanthoma: retrospective study and review of the korean literature.
Yoo MG; Kim IH
Ann Dermatol; 2014 Apr; 26(2):172-6. PubMed ID: 24882970
[TBL] [Abstract][Full Text] [Related]
5. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
6. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
[TBL] [Abstract][Full Text] [Related]
7. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
8. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
Moss M; Weber E; Hoverson K; Montemarano AD
Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological evaluation of intralesional methotrexate in different subtypes of basal cell carcinoma.
Khashaba SA; Elgarf AM; Hamed DE; Elkashishy KA; Said NM
Dermatol Ther; 2022 Apr; 35(4):e15315. PubMed ID: 35023272
[TBL] [Abstract][Full Text] [Related]
10. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
Nofal A; Alakad R; Wahid R; Hoseiny HAM
Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
[TBL] [Abstract][Full Text] [Related]
11. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
Aubut N; Alain J; Claveau J
J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
Doerfler L; Hanke CW
J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
[TBL] [Abstract][Full Text] [Related]
13. Histological findings after intralesional methotrexate treatment in cutaneous squamous cell carcinoma.
Bergón-Sendín M; Parra-Blanco V; Pulido-Pérez A; Nieto-Benito LM; Rosell-Díaz ÁM; Suárez-Fernández R
Dermatol Ther; 2020 Nov; 33(6):e14377. PubMed ID: 33030310
[TBL] [Abstract][Full Text] [Related]
14. Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Hamad J; Jolly PS
Dermatol Ther; 2021 Nov; 34(6):e15139. PubMed ID: 34549487
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
16. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
17. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
18. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior.
Weninger W; Rendl M; Pammer J; Grin W; Petzelbauer P; Tschachler E
J Cutan Pathol; 1997 Jul; 24(6):364-9. PubMed ID: 9243364
[TBL] [Abstract][Full Text] [Related]
19. Keratoacanthoma versus invasive squamous cell carcinoma: a comparison of dermatoscopic vascular features in 510 cases.
Pyne JH; Windrum G; Sapkota D; Wong JC
Dermatol Pract Concept; 2014 Jul; 4(3):37-41. PubMed ID: 25126456
[TBL] [Abstract][Full Text] [Related]
20. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
